Ligand validation:8T70

3FX: (2R)-3-(cyclohexylamino)-2-hydroxypropane-1-sulfonic acid

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8T70_3FX_B_602	77%	17%	0.138	0.977	1.09	2.51	1	3	2	0	100%	1
8T70_3FX_B_603	72%	23%	0.135	0.959	1.05	2.07	2	4	0	0	100%	1
8T70_3FX_B_604	26%	28%	0.207	0.846	1.08	1.81	2	4	1	0	100%	1
3SFX_3FX_B_522	85%	38%	0.114	0.981	1.03	1.38	1	1	2	0	100%	1
3SFY_3FX_B_522	83%	45%	0.12	0.979	0.88	1.22	-	1	2	0	100%	1
7T0C_3FX_B_618	81%	20%	0.127	0.981	1.03	2.34	1	3	2	0	100%	1
7T0B_3FX_B_3003	81%	21%	0.123	0.976	1.01	2.24	1	3	2	0	100%	1
7T08_3FX_B_602	81%	24%	0.121	0.973	1.04	2.06	2	3	2	0	100%	1
3Q7A_3FX_B_522	80%	44%	0.126	0.975	1.02	1.15	-	2	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.